These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32145315)

  • 1. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
    Kurbegovic A; Trudel M
    Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis.
    Parrot C; Kurbegovic A; Yao G; Couillard M; Côté O; Trudel M
    Hum Mol Genet; 2019 Mar; 28(5):751-763. PubMed ID: 30388220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease.
    Cai J; Song X; Wang W; Watnick T; Pei Y; Qian F; Pan D
    Genes Dev; 2018 Jun; 32(11-12):781-793. PubMed ID: 29891559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
    Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).
    Lanoix J; D'Agati V; Szabolcs M; Trudel M
    Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
    Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
    J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
    Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
    J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
    Kurbegovic A; Trudel M
    Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.
    Zhou X; Fan LX; Sweeney WE; Denu JM; Avner ED; Li X
    J Clin Invest; 2013 Jul; 123(7):3084-98. PubMed ID: 23778143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute kidney injury induces hallmarks of polycystic kidney disease.
    Kurbegovic A; Trudel M
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F740-F751. PubMed ID: 27488998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
    Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA
    Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease.
    Pandey P; Qin S; Ho J; Zhou J; Kreidberg JA
    BMC Syst Biol; 2011 Apr; 5():56. PubMed ID: 21518438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
    Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
    J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
    Wilk EJ; Howton TC; Fisher JL; Oza VH; Brownlee RT; McPherson KC; Cleary HL; Yoder BK; George JF; Mrug M; Lasseigne BN
    Mol Med; 2023 May; 29(1):67. PubMed ID: 37217845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tulp3 Is a Ciliary Trafficking Gene that Regulates Polycystic Kidney Disease.
    Legué E; Liem KF
    Curr Biol; 2019 Mar; 29(5):803-812.e5. PubMed ID: 30799240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.
    Zhou X; Fan LX; Peters DJ; Trudel M; Bradner JE; Li X
    Hum Mol Genet; 2015 Jul; 24(14):3982-93. PubMed ID: 25877301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NHA2 promotes cyst development in an in vitro model of polycystic kidney disease.
    Prasad H; Dang DK; Kondapalli KC; Natarajan N; Cebotaru V; Rao R
    J Physiol; 2019 Jan; 597(2):499-519. PubMed ID: 30242840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
    Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.